U.S. market Closed. Opens in 1 day 4 hours 1 minute

SLS | SELLAS Life Sciences Group, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
RevenueN/A1.00M7.60M1.90MN/AN/AN/AN/AN/A9.32M2.49M2.04MN/AN/AN/AN/AN/AN/A
Cost of RevenueN/A100.00K200.00KN/AN/AN/AN/A3.00K355.00K1.40M520.00KN/A20.79MN/AN/AN/A11.41MN/A
Gross ProfitN/A900.00K7.40M1.90MN/AN/AN/A-3.00K-355.00K7.92M1.97M2.04M-20.79MN/AN/AN/A-11.41MN/A
Operating Expenses37.87M42.85M32.69M18.88M17.21M31.09M21.16M31.87M34.22M60.14M35.81M21.20M20.79M16.62M17.52M14.55M11.41M2.40M
Selling, General & Admin13.86M12.58M11.32M9.60M9.92M12.77M15.09M12.01M10.61M31.34M14.60M6.58M9.25M8.75M8.63M7.50M4.67M633.00K
Research & Development24.01M30.27M21.37M9.28M7.29M18.32M6.07M19.86M23.61M28.35M21.08M14.61M11.54M7.87M8.89M7.05M6.75M1.30M
Other Operating ExpensesN/A10.00M5.70MN/AN/A-3.03MN/AN/A509.00K170.00K37.00K-13.18M9.25MN/AN/A7.50MN/AN/A
Operating Income-37.87M-41.95M-25.29M-16.98M-20.04M-31.09M-23.04M-31.87M-34.22M-52.22M-33.84M-21.20M-20.79M-16.62M-17.52M-14.55M-11.41M-2.40M
Other Expenses / Income529.00K649.00K4.36M208.00K668.00K2.54M-7.79M5.13M-4.37M13.62M-41.79M-13.18M9.30M4.63M-867.00K180.00K448.00KN/A
Before Tax Income-37.34M-41.30M-20.94M-16.77M-19.37M-29.05M-23.50M-10.86M-38.59M-36.61M-75.63M-34.38M-11.48M-11.99M-18.39M-14.37M-10.96M-2.40M
Income Tax ExpensesN/A-649.00K-237.00K-17.00K-81.00K-1.38M253.00K243.00K365.00K-15.45M1.05M-1.05M-9.30M-4.63M867.00KN/A25.00KN/A
Net Income-37.34M-40.65M-20.70M-16.76M-19.29M-27.67M-23.75M-23.55M-63.90M-36.61M-76.68M-34.97M-11.48M-11.99M-18.39M-14.37M-10.99M-2.40M
Interest ExpensesN/AN/AN/AN/A118.00K266.00K462.00K3.51M760.00K1.11M807.00K33.00KN/A5.00K-5.00KN/AN/AN/A
Basic Shares Outstanding27.78M19.40M15.48M7.98M2.56M261.54K46.81K6.64K5.17K3.98K3.01K2.08K1.21K612.00540.00458.00422.00420.00
Diluted Shares Outstanding27.78M19.40M15.48M7.98M2.56M261.54K46.81K6.64K5.17K3.98K3.01K2.08K1.21K612.00540.00458.00422.00420.00
EBITDA529.00K-31.95M-19.66M-16.40M668.00KN/A-23.04M-15.98M-37.48M-36.61M7.63M-34.38M-11.32M-11.82M-18.22M-14.24M-10.93M-2.40M
EBITDA Margin0.00%-3,195.00%-258.72%-863.00%0.00%0.00%0.00%0.00%0.00%-392.81%306.71%-1,686.80%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-37.34M-41.30M-20.94M-16.77M-19.25M-28.78M-23.04M-19.80M-62.78M-50.94M-74.82M-35.99M-20.79M-16.62M-17.52M-14.37M-10.96M-2.40M
EBIT Margin0.00%-4,130.10%-275.47%-882.84%0.00%0.00%0.00%0.00%0.00%-546.65%-3,008.40%-1,765.85%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙